Exhibit 5.1

(313) 465-7000 Fax: (313) 465-8000 www.honigman.com

March 23, 2015

Diplomat Pharmacy, Inc.

4100 S. Saginaw St.

Flint, Michigan 48507

Ladies and Gentlemen:

We have acted as counsel to Diplomat Pharmacy, Inc., a Michigan corporation (the “Company”), in connection with the preparation and filing with the Securities and Exchange Commission (the “Commission”) of a Registration Statement on Form S-1 (Registration No. 333-202750) of the Company (as amended through the date hereof and including all exhibits thereto, the “Registration Statement”), including a related prospectus filed with the Registration Statement (the “Prospectus”), for registration under the Securities Act of 1933, as amended (the “Securities Act”), of a maximum of 8,510,000 of the Common Shares, no par value, of the Company (the “Common Stock”), comprised of (i) up to an aggregate of 4,955,000 shares of Common Stock to be sold by the Company, which includes 555,000 shares that may be sold by the Company upon exercise of the option to purchase additional shares granted to the underwriters (the “Company Shares”), and (ii) up to an aggregate of 3,555,000 shares of Common Stock to be sold by certain shareholders of the Company, which includes 555,000 shares that may be sold by such shareholders upon exercise of the option to purchase additional shares granted to the underwriters (the “Selling Shareholder Shares,” and together with the Company Shares, the “Shares”). The Shares are to be sold to the underwriters for resale to the public as described in the Registration Statement and pursuant to the underwriting agreement referred to in the Registration Statement (the “Underwriting Agreement”).

Based upon our examination of such documents and other matters as we deem relevant, we are of the opinion that (i) the Company Shares covered by the Registration Statement have been duly authorized by the Company and, when issued and sold by the Company as described in the Registration Statement and in the manner set forth in the Underwriting Agreement, against payment therefore, will be validly issued, fully paid and non-assessable, and (ii) the Selling Shareholder Shares have been duly authorized by the Company, and are validly issued, fully paid and non-assessable.

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to our firm under the caption “Legal Matters” in the Prospectus included in the Registration Statement.  In giving such consents, we do not admit that we are within the category of persons whose consent is required by Section 7 of the Securities Act or the rules and regulations of the Commission under the Securities Act.

Very truly yours,

/S/ HONIGMAN MILLER SCHWARTZ AND COHN LLP

JVK/MKB/RZK/MSB

2290 First National Building · 660 Woodward Avenue · Detroit, Michigan 48226-3506

Detroit · Lansing · Oakland County · Ann Arbor · Kalamazoo